Fischer-Tropsch synthesis over ruthenium-promoted Co/Al2O3 catalyst with different reduction procedu

来源 :天然气化学(英文版) | 被引量 : 0次 | 上传用户:rcs84719
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The effect of reduction procedure on catalyst properties,activity and products selectivity of ruthenium-promoted Co/γ-Al2O3 catalyst in Fischer-Tropsch synthesis(FTS)was investigated.Catalyst samples were reduced with different reduction gas compositions and passivated before being characterized by TPR and XRD techniques.Different activity and product selectivity analyses were also performed.These results showed that the catalyst dispersion,particle size,and the degree of reduction changed with different reduction gas compositions,which were resulted from the water partial pressures in reduction process that give varying degrees of interaction with the support.It has been suggested that the FTS activity of cobalt catalyst was directly dependent on the catalyst reducibility.A reduction gas with a molar ratio of H2/He = 1 was used to prevent the formation of Co-support compound during catalyst reduction.
其他文献
Various Cu/ZnO/Al2O3 catalysts have been synthesized by different aluminum emulsions as aluminum sources and their performances for methanol synthesis from syng
目的 探讨寻常型天疱疮(pemphigus vulgaris,PV)患者抗原特异性Th1和Th2细胞在不同疾病阶段的变化,进一步了解自身反应性T细胞在疾病中的作用.方法 收集24例PV患者资料,合成
期刊
目的 评价瑞舒伐他汀治疗老年冠心病患者高胆固醇血症的疗效及按入院次序安全性,并与辛伐他汀作对比.方法 采用单盲随机对照的研究方法将87例年龄大于60岁的冠心病高胆固醇血症患者按入院次序随机分为瑞舒伐他汀组(44例)和辛伐他汀组(43例).瑞舒伐他汀组给予瑞舒伐他汀10 mg,1次/d;辛伐他汀组给予辛伐他汀20 mg,1次/d,疗程8周,观察两药的疗效及安全性.结果 瑞舒伐他汀组经8周治疗,血浆L
患者男,52岁,无药物过敏史.因车祸于2009年12月21日行左胫骨平台内固定术.2010年1月4日查房,患者恢复良好.体格检查:体温36.8℃,脉搏80次/min,血压130/80 mm Hg(1 mm Hg=0.133 kPa)、呼吸20次/min.心肺听诊未见明显异常,左小腿略肿胀,切口愈合良好。
期刊
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥
21世纪实在是一个全新发展的时代,是一个充满机遇与创新的最好的时代,科学技术一直在飞速发展,不断创造着一个又一个令人振奋的奇迹.电气工程的质量也是这些奇迹能够被成功缔
目的 观察重组人脑利钠肽(rhBNP)治疗急性失代偿性心力衰竭(ADHF)患者的临床疗效对血浆N端脑利钠肽(NT-proBNP)、血流动力学参数的影响.方法 112例住院ADHF患者,完全随机分成对照组和rhBNP组:对照组54例,予以常规抗心力衰竭治疗;rhBNP组58例,在常规抗心力衰竭治疗基础上加用新活素(冻干rhBNP)静脉注射治疗.留置Swan-Ganz导管监测患者血流动力学参数,比较2
期刊